Ninth International Congress on the Future of Breast Cancer

An international educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed and controversial issues debated in panel discussions. Strategies for optimizing the use of endocrine therapy, conventional chemotherapy, and targeted therapies will be presented. Evolving diagnostic approaches to identify the driving mutations or pathways in breast cancers will be thoroughly discussed along with the therapies targeting those mutations. Controversial issues in the surgical and radiotherapeutic management of breast cancer will also be discussed and debated. The format will include didactic sessions from thought leaders, question-and-answer panel discussions, and ample time for participant interaction with faculty.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
Learning Objectives

At the conclusion of this congress, you should be able to:

Discuss the key highlights from preclinical and clinical breast cancer research presented or published in the past year, including summaries from major international